Meta H M Diekstra

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Metastatic Renal Cell Carcinoma

Decision Making

Clinical Practice

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Emma C Bernsen, Valery J Hogenes, Bastiaan Nuijen, Lidwien M Hanff, Alwin D R Huitema, Meta H M Diekstra
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 14 (12) (2022)
Emma C Bernsen, Valery J Hogenes, Bastiaan Nuijen, Lidwien M Hanff, Alwin D R Huitema, Meta H M Diekstra
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 14 (12) (2022)
Meta H M Diekstra, Jesse Joachim Swen, Loes F M van der Zanden, Sita H Vermeulen, Epie Boven, Ron H J Mathijssen, Koya Fukunaga, Taisei Mushiroda, Fumiya Hongo, Egbert Oosterwijk, Anne Cambon-Thomsen, Daniel Castellano, Achim Fritsch, Jesus Garcia Donas, Cristina Rodriguez-Antona, Rob Ruijtenbeek, Marius T Radu, Tim Eisen, Kerstin Junker, Max Roessler, Ulrich Jaehde, Tsuneharu Miki, Stefan Böhringer, Michiaki Kubo, Lambertus A L M Kiemeney, Henk-Jan Guchelaar
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. Cancers 14 (12) (2022)
Emma C Bernsen, Valery J Hogenes, Bastiaan Nuijen, Lidwien M Hanff, Alwin D R Huitema, Meta H M Diekstra
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 14 (12) (2022)
Emma C Bernsen, Valery J Hogenes, Bastiaan Nuijen, Lidwien M Hanff, Alwin D R Huitema, Meta H M Diekstra
Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 14 (12) (2022)